1.

Record Nr.

UNINA9910958583003321

Autore

Torrents Eduard

Titolo

The ribonucleotide reductase family : genetics and genomics / / Eduard Torrents, Margareta Sahlin and Britt-Marie Sjoberg

Pubbl/distr/stampa

New York, : Nova Biomedical Books, c2009

ISBN

1-60741-670-0

Edizione

[1st ed.]

Descrizione fisica

1 online resource (109 p.)

Collana

Novinka The ribonucleotide reductase family

Altri autori (Persone)

SahlinMargareta

SjobergBritt-Marie

Disciplina

572/.791

Soggetti

Oxidoreductases

Enzymes

Genetics

Genomics

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Description based upon print version of record.

Nota di bibliografia

Includes bibliographical references (p. [65]-87) and index.

Nota di contenuto

Intro -- THE RIBONUCLEOTIDEREDUCTASE FAMILY:GENETICS AND GENOMICS -- Contents -- Preface -- Introduction -- RNR Classification and Occurrence -- Class I RNRs -- Class II RNRs -- Class III RNRs -- RNR distribution as seen in RNRdb -Ribonucleotide Reductase Database -- Atypical and Unconventional RNRs -- RNR Diversification -- Modularity Hypothesis for RNR ClassDiversificatio -- Regulation of RNRs -- Archaea -- Eubacteria -- Mutational Studies in RNRs -- RNR as an Antiproliferative Targetfor Disease Control -- Substrate Analogues -- Radical Scavengers Attacking the TyrosylRadical -- Iron Chelators -- Peptidomimetics Corresponding to the CTerminusof NrdB -- Manipulating the Expression of RNR -- Other Potential Inhibitors and AllostericNucleotide Analogues -- Future Antiproliferative Regimes -- Acknowledgments -- References -- Index.

Sommario/riassunto

Ribonucleotide reductase (RNR), has a central role in DNA replication and repair by catalysing production of deoxyribonucleotides from the corresponding ribonucleotides. The authors describe a comprehensive summary of how the expression of RNR genes is regulated in several eubacterial organisms and in yeast. Due to RNR's importance for the realisation of DNA replication, it has been recognised as a possible



target for antiproliferative therapy. The authors present a comprehensive summary of RNR-specific inhibitors that have reached clinical trials and/or are currently used in clinical therapy.